A specific batch of antidepressant medication has been recalled. It concerns Sertraline 100 mg from the company Amarox Limited.
During packaging, an error occurred in which a different type of medication was placed in some of the packs.
Both types of medication are produced at the same facility, and the error is believed to have occurred in the final stage of the packaging process, according to The Sun.
Authorities take action
The batch originates from the United Kingdom, and British health authorities have responded by halting the distribution of the affected batch with the number V2500425.
Also read: Donald Trump’s hands draw attention again after meeting with King Charles
Pharmacies and doctors are required to identify patients who may have received the medication and ask them to return it.
Patients are also encouraged to check their packages themselves to ensure that the contents are correct.
Possible side effects and risk
Both medicines are used to treat depression and anxiety.
If the wrong medication is taken, it may lead to side effects such as nausea, headaches, and changes in sleep patterns.
Also read: How your body reveals if you have liver cirrhosis
Certain groups are more vulnerable, including the elderly, young people, and individuals with specific medical conditions. They may require additional monitoring by a doctor.
The error was first discovered when a patient noticed that the contents of the package did not match the labeling.
Sources: The Sun.
Also read: More people are choosing canned mackerel – and there’s a good reason
Also read: Lifestyle diseases can increase cancer risk by up to 30 percent
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.